Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Anti-Aging Services Market

ID: MRFR/HC/6110-HCR
130 Pages
Vikita Thakur
Last Updated: May 15, 2026
Anti-Aging Services Market Research Report Information by Type of Service (Microdermabrasion, Liposuction, Sclerotherapy, Chemical Peel, and Others), Service Provider (Hospitals, Dermatology Clinics, and Others), and Region Forecast till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Type (USD Billion) | |
      1. 4.1.1 Microdermabrasion | |
      2. 4.1.2 Breast Augmentation | |
      3. 4.1.3 Liposuction | |
      4. 4.1.4 Chemical Peel | |
      5. 4.1.5 Sclerotherapy | |
      6. 4.1.6 Intense Pulsed Light | |
      7. 4.1.7 Botox Treatment | |
      8. 4.1.8 Dermal Fillers | |
      9. 4.1.9 Others |
    2. 4.2 Healthcare, BY Service Provider (USD Billion) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Dermatology Clinics | |
      3. 4.2.3 Salons | |
      4. 4.2.4 Others |
    3. 4.3 Healthcare, BY Region (USD Billion) | |
      1. 4.3.1 North America | | |
        1. 4.3.1.1 US | | |
        2. 4.3.1.2 Canada | |
      2. 4.3.2 Europe | | |
        1. 4.3.2.1 Germany | | |
        2. 4.3.2.2 UK | | |
        3. 4.3.2.3 France | | |
        4. 4.3.2.4 Russia | | |
        5. 4.3.2.5 Italy | | |
        6. 4.3.2.6 Spain | | |
        7. 4.3.2.7 Rest of Europe | |
      3. 4.3.3 APAC | | |
        1. 4.3.3.1 China | | |
        2. 4.3.3.2 India | | |
        3. 4.3.3.3 Japan | | |
        4. 4.3.3.4 South Korea | | |
        5. 4.3.3.5 Malaysia | | |
        6. 4.3.3.6 Thailand | | |
        7. 4.3.3.7 Indonesia | | |
        8. 4.3.3.8 Rest of APAC | |
      4. 4.3.4 South America | | |
        1. 4.3.4.1 Brazil | | |
        2. 4.3.4.2 Mexico | | |
        3. 4.3.4.3 Argentina | | |
        4. 4.3.4.4 Rest of South America | |
      5. 4.3.5 MEA | | |
        1. 4.3.5.1 GCC Countries | | |
        2. 4.3.5.2 South Africa | | |
        3. 4.3.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Allergan (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Revance Therapeutics (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Galderma (CH) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Hugel (KR) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Medytox (KR) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Ipsen (FR) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Sientra (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Medytox (KR) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Hugel (KR) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY SERVICE PROVIDER |
    8. 6.5 CANADA MARKET ANALYSIS BY TYPE |
    9. 6.6 CANADA MARKET ANALYSIS BY SERVICE PROVIDER |
    10. 6.7 EUROPE MARKET ANALYSIS |
    11. 6.8 GERMANY MARKET ANALYSIS BY TYPE |
    12. 6.9 GERMANY MARKET ANALYSIS BY SERVICE PROVIDER |
    13. 6.10 UK MARKET ANALYSIS BY TYPE |
    14. 6.11 UK MARKET ANALYSIS BY SERVICE PROVIDER |
    15. 6.12 FRANCE MARKET ANALYSIS BY TYPE |
    16. 6.13 FRANCE MARKET ANALYSIS BY SERVICE PROVIDER |
    17. 6.14 RUSSIA MARKET ANALYSIS BY TYPE |
    18. 6.15 RUSSIA MARKET ANALYSIS BY SERVICE PROVIDER |
    19. 6.16 ITALY MARKET ANALYSIS BY TYPE |
    20. 6.17 ITALY MARKET ANALYSIS BY SERVICE PROVIDER |
    21. 6.18 SPAIN MARKET ANALYSIS BY TYPE |
    22. 6.19 SPAIN MARKET ANALYSIS BY SERVICE PROVIDER |
    23. 6.20 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    24. 6.21 REST OF EUROPE MARKET ANALYSIS BY SERVICE PROVIDER |
    25. 6.22 APAC MARKET ANALYSIS |
    26. 6.23 CHINA MARKET ANALYSIS BY TYPE |
    27. 6.24 CHINA MARKET ANALYSIS BY SERVICE PROVIDER |
    28. 6.25 INDIA MARKET ANALYSIS BY TYPE |
    29. 6.26 INDIA MARKET ANALYSIS BY SERVICE PROVIDER |
    30. 6.27 JAPAN MARKET ANALYSIS BY TYPE |
    31. 6.28 JAPAN MARKET ANALYSIS BY SERVICE PROVIDER |
    32. 6.29 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    33. 6.30 SOUTH KOREA MARKET ANALYSIS BY SERVICE PROVIDER |
    34. 6.31 MALAYSIA MARKET ANALYSIS BY TYPE |
    35. 6.32 MALAYSIA MARKET ANALYSIS BY SERVICE PROVIDER |
    36. 6.33 THAILAND MARKET ANALYSIS BY TYPE |
    37. 6.34 THAILAND MARKET ANALYSIS BY SERVICE PROVIDER |
    38. 6.35 INDONESIA MARKET ANALYSIS BY TYPE |
    39. 6.36 INDONESIA MARKET ANALYSIS BY SERVICE PROVIDER |
    40. 6.37 REST OF APAC MARKET ANALYSIS BY TYPE |
    41. 6.38 REST OF APAC MARKET ANALYSIS BY SERVICE PROVIDER |
    42. 6.39 SOUTH AMERICA MARKET ANALYSIS |
    43. 6.40 BRAZIL MARKET ANALYSIS BY TYPE |
    44. 6.41 BRAZIL MARKET ANALYSIS BY SERVICE PROVIDER |
    45. 6.42 MEXICO MARKET ANALYSIS BY TYPE |
    46. 6.43 MEXICO MARKET ANALYSIS BY SERVICE PROVIDER |
    47. 6.44 ARGENTINA MARKET ANALYSIS BY TYPE |
    48. 6.45 ARGENTINA MARKET ANALYSIS BY SERVICE PROVIDER |
    49. 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    50. 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE PROVIDER |
    51. 6.48 MEA MARKET ANALYSIS |
    52. 6.49 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    53. 6.50 GCC COUNTRIES MARKET ANALYSIS BY SERVICE PROVIDER |
    54. 6.51 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    55. 6.52 SOUTH AFRICA MARKET ANALYSIS BY SERVICE PROVIDER |
    56. 6.53 REST OF MEA MARKET ANALYSIS BY TYPE |
    57. 6.54 REST OF MEA MARKET ANALYSIS BY SERVICE PROVIDER |
    58. 6.55 KEY BUYING CRITERIA OF HEALTHCARE |
    59. 6.56 RESEARCH PROCESS OF MRFR |
    60. 6.57 DRO ANALYSIS OF HEALTHCARE |
    61. 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    62. 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    63. 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE |
    64. 6.61 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
    65. 6.62 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
    66. 6.63 HEALTHCARE, BY SERVICE PROVIDER, 2024 (% SHARE) |
    67. 6.64 HEALTHCARE, BY SERVICE PROVIDER, 2024 TO 2035 (USD Billion) |
    68. 6.65 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    69. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    70. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    71. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    72. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    73. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    74. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    75. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    76. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    77. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    78. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    79. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    80. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    81. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    82. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    83. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    84. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    85. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    86. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    87. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    88. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    89. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    90. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    91. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    92. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    93. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    94. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    95. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    96. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    97. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    98. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY SERVICE PROVIDER, 2025-2035 (USD Billion) |
    99. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    100. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Microdermabrasion
  • Breast Augmentation
  • Liposuction
  • Chemical Peel
  • Sclerotherapy
  • Intense Pulsed Light
  • Botox Treatment
  • Dermal Fillers
  • Others

Healthcare By Service Provider (USD Billion, 2025-2035)

  • Hospitals
  • Dermatology Clinics
  • Salons
  • Others